Platelet Response to Low-Dose Enteric-Coated Aspirin in Patients With Stable Cardiovascular Disease

This publication has 24 references indexed in Scilit:

• Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass Surgery
  Circulation, 2003
• A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
  Journal of the American College of Cardiology, 2003
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Profile and prevalence of aspirin resistance in patients with cardiovascular disease
  The American Journal of Cardiology, 2001
• Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey.
  The American Journal of Cardiology, 1999
• Synergism of platelet-aggregating agents. Role of elevation of cytoplasmic calcium.
  Journal of Clinical Investigation, 1987
• Physiologic variables affecting thromboxane B2 production in human whole blood
  Thrombosis Research, 1985
• Monitoring the entry of new platelets into the circulation after ingestion of aspirin
  Blood, 1983
• Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy Subjects
  Journal of Clinical Investigation, 1982
• Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
  Proceedings of the National Academy of Sciences, 1975